111 Stock-Based Compensation 2018-2024 | YI

111 stock-based compensation from 2018 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors

111 Stock-Based Compensation 2018-2024 | YI

111 stock-based compensation from 2018 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$35.1B
Tempus AI (TEM)$7B
Hims & Hers Health (HIMS)$6B
Inspire Medical Systems (INSP)$4.5B
IRhythm Technologies (IRTC)$3.2B
Privia Health (PRVA)$2.9B
Schrodinger (SDGR)$1.9B
Clover Health Investments (CLOV)$1.8B
Enovis (ENOV)$1.8B
Omnicell (OMCL)$1.4B
Phreesia (PHR)$1.4B
Azenta (AZTA)$1.2B
10x Genomics (TXG)$918M
Butterfly Network (BFLY)$568M
Fulgent Genetics (FLGT)$551M
Talkspace (TALK)$450M
Veradigm (MDRX)$449M
Standard BioTools (LAB)$440M
TruBridge (TBRG)$363M
Claritev (CTEV)$325M
Health Catalyst (HCAT)$270M
Nyxoah SA (NYXH)$206M
SOPHiA GENETICS SA (SOPH)$189M
Pulmonx (LUNG)$182M
American Well (AMWL)$109M
EUDA Health Holdings (EUDA)$100M
Retrieve Medical Holdings (RMHI)$82M
MDxHealth SA (MDXH)$76M
P3 Health Partners (PIII)$66M
CareCloud (CCLD)$60M